The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
NCT07183150 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-09-19
Summary
The main purpose of this study is to evaluate the reasonable range of No.4sb lymph node dissection of locally advanced distal gastric cancer.
Conditions
- Gastric Cancer (GC)
- No.4sb
Sponsors & Collaborators
-
Tianjin Medical University Cancer Institute and Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-18
- Primary Completion
- 2027-08-17
- Completion
- 2027-12-30
Countries
- China
Study Locations
More Related Trials
-
Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer(IDEAL Stage 2b)
NCT06788548 ·Status: RECRUITING ·Phase: NA
-
Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01544413 ·Status: COMPLETED ·Phase: NA
-
Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer
NCT02229058 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery
NCT05844371 ·Status: UNKNOWN ·Phase: PHASE2
-
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
NCT03961373 ·Status: RECRUITING ·Phase: PHASE3
-
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
NCT01839500 ·Status: COMPLETED
-
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
NCT01305993 ·Status: UNKNOWN ·Phase: PHASE2
-
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer
NCT02423278 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
the Optimal Surveillance Frequency for Stage II/III Gastric Cancer
NCT05465993 ·Status: COMPLETED
-
Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer
NCT02240524 ·Status: UNKNOWN ·Phase: PHASE3
-
Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph Node Metastasis
NCT06534814 ·Status: RECRUITING
-
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
NCT04440605 ·Status: UNKNOWN
-
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer
NCT05586061 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
NCT00149279 ·Status: COMPLETED ·Phase: PHASE3
-
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
NCT05361161 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Benefit Population Atlas of nICT Versus nCT for LAGC
NCT07098104 ·Status: COMPLETED
-
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
NCT03632746 ·Status: UNKNOWN
-
Trastuzumab Based Therapy in HER2 Positive AGC
NCT03024450 ·Status: COMPLETED
-
A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy
NCT04108494 ·Status: RECRUITING ·Phase: NA
-
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981 ·Status: RECRUITING
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING
-
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer
NCT04795063 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
NCT06492317 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Predicting the Efficacy in Advanced Gastric Cancer.
NCT06490055 ·Status: COMPLETED
-
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
NCT02004769 ·Status: COMPLETED ·Phase: PHASE2